Market

To develop a vaccine against visceral leishmaniasis

The company plans to support India’s aim of achieving 90 per cent coverage through its expanded programme by 2020

The investment will be made in two tranches

Eight therapies have outgrown the IPM growth and all therapies have double digit growths

Conference attended by regulatory affairs experts and pharma companies

As the Obama administration chalks out a plan to combat the growing menace of antibiotic resistance, Jim ‘o’ Neill who was…

The decision was taken by CCEA, chaired by Prime Minister Narendra Modi

Dr Reddy’s Laboratories and its subsidiary, Promius Pharma announced the filing of three 505(b)(2) New Drug Applications (NDAs)…

This facility is spread across an area of 30,000 sq ft and is equipped with a 98-bed facility

Don’t dilute Patent Act, blogs Swadeshi Jagaran Manch co-convenor